Newsbenzinga
TherapeuticsMD Q2 EPS $0.01 Down From $0.05 YoY, Sales $869.000K Down From $952.000K YoY
· Published
Article summary
Please check the source for details.
An excerpt from the original article.Loading news article.
Please check the source for details.
An excerpt from the original article.
Comments —
Loading comments…